ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

N4P N4 Pharma Plc

0.80
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 198,696 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.40 1.45M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.80p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.00p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.45 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.40.

N4 Pharma Share Discussion Threads

Showing 2001 to 2024 of 8600 messages
Chat Pages: Latest  92  91  90  89  88  87  86  85  84  83  82  81  Older
DateSubjectAuthorDiscuss
09/2/2018
13:23
mmmm you cant buy these in any large amount so have to buy small amount on any sells, is this normally the case?
jimmmy
09/2/2018
13:18
The next big drugs tie up is going to be VAL. Imminent RNS confirming a deal with one of the big Pharmas. RNS today letting holders know how many share options the directors have just been awarded. The next one will be the biggy! Broker talks of 30p+ initially on the latest drug test news that is due too.
cudmore
09/2/2018
13:18
Looks like we could be in for an interesting afternoon ...
jakleeds
09/2/2018
13:16
Jim,
All matters relating to the Sildenafil patent are in the link below:

hughwilson
09/2/2018
13:05
Jim,
I know that the full patent award will not be until 2019.
I think the exact date is May 31st but I would have to double check on that.
A good explanation is given in the last presentation when Nigel says that the reason that no one had heard of N4 was because of the patent publication had been awaited and now that it had been published N4 were free to talk to partners and investors.

hughwilson
09/2/2018
12:31
OK thanks.

The reformulated patents shouldn't be a problem I guess. Nuvec has moved onto the 2nd stage so is going OK.

Any idea of time scales for getting fully patent? That would be a big win. At least, feels like it to me.

jimbobaroony
09/2/2018
12:14
Jim, there is a defined process in patent protection before it is signed off but the most important part of that process is that the patent is lodged and published. Once that is done no other company can copy them without infringing on the patent even though the patent is technically pending.
hughwilson
09/2/2018
12:01
OK. I am definitely not an expert on patents so need to understand something. N4p have agreements in place to exclusively license patents from OPAL and Queensland uni. What is the status of those patents? I have been assuming patent pending. Is that wrong?
jimbobaroony
09/2/2018
11:47
PS.
One of the things making N4 a prime bid target is that everything they do is fully patented. If any company want to take advantage of N4`s tech, they have to buy them out to get access to their patents.

hughwilson
09/2/2018
11:44
Jim, the difference is that they have signed a deal.
While N4 have no signed deal as yet, they do have a collaboration with one of the biggest pharma`s in the world that is likely to lead to a deal and they are just about to set off on a deal seeking mission to Japan paid for by the UK government.

hughwilson
09/2/2018
11:41
The nanomedicine market is set to be worth $350 billion by 2025



The attraction of the Nuvec side of the business is that to develop medicines for this market costs 100's of millions. N4P don't get involved in that and will just (hopefully) license out Nuvec as a drug delivery mechanism for the pharmas / biotechs whose objective is to take a drug through the costly process. Yet, despite not having any of the expense, they can still negotiate milestones for any drug they license Nuvec out for and negotiate a royalty if the drug ever reaches the market.

All there in the November presentation :-

nick2412
09/2/2018
11:38
The difference I assume is they have a fully approved and patent protected product
jimbobaroony
09/2/2018
11:28
escapetohome,
I fully expect a bid to come in. What gives me comfort is that Nigel has a good idea of the value that can be created in N4 and would not sell it cheap.I think a price of about £200m would secure in in the near term but if it is allowed to build then it would be much more.
The price of N4 is stupid at the moment and I do not think the market or investors has the vision to see the wealth creation that is possible here.
The company I spoke of yesterday that rose 44% in one day because of signing just one nanoparticle deal is valued at £97 million and yet here we are with all the potential and big backers at the £20m mark.
Crazy but it is what it is.
Fully expect us to be multiples of where we are now in the near future.

hughwilson
09/2/2018
11:14
Not a chance in a trillion years you will get my shares at this price is my response to any company stalking n4p with a view to making a bid.
escapetohome
09/2/2018
10:53
I should add that I believe that the trial will be a complete success.
Given the amount of warrant money already in plus that which could flow in between now and April, I believe that Nigel will have sufficient capital to go it alone with the full trials giving them 10-12% royalties in a billions of dollars market.
That not only shows the quality of Nigel as a CEO but also the confidence in him by the main backers.

hughwilson
09/2/2018
10:45
Urigem,
The viagra trials are ongoing. N4 had already notified the market that trials would start in January so no RNS was required.
Results will be by the end of April but in effect could be anytime during April, it just depends on how the tests go.

hughwilson
09/2/2018
10:42
Hugh seems to be AWOL
keithlemon
09/2/2018
09:28
Time to continue the rerate to 37p:)))
ch1rp
09/2/2018
08:52
I wish advfn would sort their issues out !!
jakleeds
09/2/2018
08:26
Missed that , thought I would wait and was just about to take some , but limits were tiny. Never mind
urigem
09/2/2018
08:24
As we move North you'll find others have the confidence we're climbing out of the dip.
parob
09/2/2018
08:20
Another 17440 added to my holding too.
parob
09/2/2018
08:12
I just managed to add some more at 22.3p. Seems a good price to me.
bdog51
09/2/2018
07:42
with a 1000 point drop one the dow, I could get a good change to add. I must admit i didnt thin we would get this low, so need to stick by my plans and add on the weakness, although my top ups the other day now look poorly timed - hey Ho.
urigem
Chat Pages: Latest  92  91  90  89  88  87  86  85  84  83  82  81  Older

Your Recent History

Delayed Upgrade Clock